-
Loading metrics
A randomized, double-blind, active-control trial to evaluate the efficacy and safety of a three day course of tafenoquine monotherapy for the treatment of Plasmodium vivax malaria
-
Mark M. Fukuda ,
Roles Conceptualization, Data curation, Formal analysis, Investigation, Writing – original draft, Writing – review & editing
* E-mail: mark.fukuda@afrims.org
Affiliation Armed Forces Research Institute of Medical Science, Bangkok, Thailand
⨯ - Srivicha Krudsood,
- Khadeeja Mohamed,
- Justin A. Green,
- Sukhuma Warrasak,
- Harald Noedl,
- Ataya Euswas,
- Mali Ittiverakul,
- Nillawan Buathong,
- Sabaithip Sriwichai,
- R. Scott Miller,
- Colin Ohrt
http://orcid.org/0000-0001-5337-8937
A randomized, double-blind, active-control trial to evaluate the efficacy and safety of a three day course of tafenoquine monotherapy for the treatment of Plasmodium vivax malaria
- Mark M. Fukuda,
- Srivicha Krudsood,
- Khadeeja Mohamed,
- Justin A. Green,
- Sukhuma Warrasak,
- Harald Noedl,
- Ataya Euswas,
- Mali Ittiverakul,
- Nillawan Buathong,
- Sabaithip Sriwichai
x
- Published: November 9, 2017
- https://doi.org/10.1371/journal.pone.0187376